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Abstract 
Introduction: Spontaneous bacterial peritonitis (SBP) is the bacterial infection of ascitic fluid in the absence of 
other apparent causes. It is the most prevalent and serious infection in cirrhosis and leads to significant morbidity 
and mortality. The frequency of SBP in hospitalized patients with cirrhosis varies from 7 to 23% in the west and it 
is around 33% in Pakistan. Our study aim was to determine the frequency of microbial organisms isolated from 
spontaneous bacterial peritonitis in cirrhotic patients. 
Materials and Methods: We did a cross-sectional study at the Department of Medicine, Fauji Foundation 
Hospital Rawalpindi for 6 months. Cirrhosis was diagnosed on the bases of clinical, biochemical and 
ultrasonography findings. Peripheral blood samples were obtained for the evaluation of complete blood cell 
count, polymorphonuclear leukocyte count, albumin and coagulation parameters. At the same time, the patients 
underwent paracentesis and a 20ml ascitic fluid sample was taken for culture sensitivity along with routine 
biochemical examination from the pathology department lab at our hospital. 
Results: A total of 150 patients were enrolled according to the inclusion criteria of the study. The mean age (yrs) 
of patients was 32.3+9.31. The frequency and percentages of male and female patients were 70 (46.7) and 80 (53.3) 
respectively. Frequency and percentages of E Coli and streptococcal pneumonia were 94 (62.7) and 34 (22.7) 
respectively, whereas frequency and percentages of staph aureus and Klebsiella were 22 (14.7). 
Conclusion: SBP is quite common in patients with cirrhosis. It should be suspected in all such cases presenting 
with typical or atypical features. E Coli was the most common causative organisms in our study but gram-positive 
organisms were quite frequent as well.  
Keywords: SBP, Cirrhosis, Peritonitis. 
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Introduction 
 
Spontaneous bacterial peritonitis (SBP) is an infection 
of ascitic fluid without any other measurable cause.1 It 
contributes to significant morbidity and mortality in 
cirrhotic patients as it also leads to renal and hepatic 
impairment.2 In hospitalized patients with cirrhosis, its 
prevalence ranges from 7 to 23% in world-wide and 
around 33% in Pakistan.3 The in-hospital mortality rate 
can reach between 20%-40% despite infection control 
strategies. Recent studies have shown that the 
prevalence of multidrug-resistant bacteria is increasing 
in these patients.4 
Pathogenesis of spontaneous bacterial peritonitis 
involves the translocation of the normal flora of the 
gut into the mesenteric lymph nodes and then ascitic 
fluid.5 In one study it is assumed that the etiology of 
spontaneous bacterial peritonitis is changing which is 
supported by frequent failure of cefotaxime previously 
considered as a treatment of choice for this disease.6 In 
Literature the most common organisms causing 
spontaneous bacterial peritonitis are Gram-negative 
rods including E Coli and Klebsiella. In some studies, 
gram-positive rods are considered the most common 
organisms and examples are Enterococcus Faecalis 
and Strep Viridens. In another study, the frequency of 
occurrence of E Coli is 66 %, Streptococcal Pneumonia 
16.0%, Staph aureus, and Klebsiella was 8%7 
respectively. 
Recent studies suggest that antibiotic resistance of 
gram-negative bacteria is on the rise along with an 
increased prevalence of gram-positive bacteria in SBP, 
so importance must be given to this change in order to 
improve clinical outcomes in such patients.7 
Previously gram-negative bacteria especially entero-
bacteriaceae were the most common organisms 
causing spontaneous bacterial peritonitis but some 
studies report gram-positive cocci to be the most 
common bacteria in culture-positive SBP and a variety 
of other drug-resistant microorganisms have also 
emerged.8 As a result of high rates of changing 
organisms in SBP, the choice of optimal antibiotic 
therapy is vital in individual patients.9 The 
explanations of antibiotic resistance to different 
organisms in SBP are the exposure of patients to the 
hospital environment, invasive diagnosis maneuvers 
and the use of prophylactic antibiotic therapy8. In 
order to decrease mortality in SBP, it is important to 
administer appropriate antibiotics as soon as possible 
after determining the microbial organism in ascitic 
fluid culture report.9 
Spontaneous bacterial peritonitis is a serious 
complication of cirrhosis of the liver and needs to be 
addressed as early as possible. In order to start an 
empirical antibiotic, it is important to know the 
spectrum of pathogens involved in this disease as soon 
as possible. The prognosis of these patients is related 
to accurate diagnosis and appropriate treatment as it 
decreases the mortality rate.10 This study will 
determine the frequency of occurrence of different 
organisms in the pathogenesis of spontaneous 
bacterial peritonitis and thus increase our information 
in order to use empirical antibiotics as this will help to 
decrease the SBP associated mortality. 
 
Materials and Methods 
 
It was a Cross-sectional study done at the Department 
of Medicine, Fauji Foundation Hospital Rawalpindi for 
six months. The study was aimed to determine the 
frequency of microbial organisms isolated from 
patients with spontaneous bacterial peritonitis having 
chronic liver disease. Cirrhosis of liver was defined by 
characteristic ultrasonographic findings, shrunken 
liver, nodular regeneration, portal hypertension 
(portal vein diameter greater than 11mm) and 
splenomegaly (size greater than 11 cm) done by an 
expert Radiologist. Spontaneous bacterial peritonitis 
was defined on ascites fluid routine examination 
having WBC count >250/mm and positive ascitic fluid 
gram stain and culture. The sample size was calculated 
using the WHO sample size calculator with a 
confidence interval of 95%, and a sample of 165 
patients was calculated for the study. Patients were 
taken through non-probability consecutive sampling 
and all patients with liver cirrhosis, ascites and SBP 
irrespective of gender and age were recruited. Patients 
already taking antibiotics within 10 days, patients with 
a history of an abdominal surgical procedure in the 
preceding month and patient with other causes of 
increased polymorphonuclear leukocyte count in the 
ascitic fluid such as tuberculosis, pancreatitis, 
peritoneal carcinomatosis, and malignancy were 
excluded based on previous history and medical 
record.  
Patients were included after taking informed consent 
for using their data in this research. Peripheral blood 
samples were obtained for the evaluation of complete 
blood cell count, polymorphonuclear leukocyte count, 
biochemical markers for example albumin and 
coagulation. At the same time, the patients underwent 
paracentesis and a 20ml ascitic fluid sample was taken, 
out of which 10ml was inoculated into a blood culture 
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bottle and send for culture sensitivity along with the 
remaining 10ml for routine biochemical examination 
to pathology department lab at our hospital. The 
organism was grown within 72 hours and the growth 
of the organism in gram stain report was verified by a 
pathologist at the hospital lab. All the data were 
analyzed using the software SPSS version 17. Values of 
continuous variables like age, polymorph nuclear cell 
count were expressed as mean +SD. Categorical 
variables like gender and frequency of microbial 
organisms were expressed as percentages. 
 
Results 
 
Out of 165 recruited patients, data of 150 patients was 
available for final analysis. The rest of the 15 patient’s 
data was excluded due to various reasons like 
withdrawal of consent, contaminated samples and loss 
of follow up of patients. In our study, the mean age of 
patients was 32.3+9.31years with ranges from 25 to 70 
years. The frequency and percentages of male patients 
were 70 (46.7), whereas the frequency and percentages 
of female patients were 80 (53.3).  Frequency and 
percentages of E Coli and streptococcal pneumonia 
were 94 (62.7) and 34 (22.7) respectively, whereas 
frequency and percentages of Staphauerous and 
Klebsiella were 22 (14.7), as shown in Table 1. 
Effect modifier like Age (yrs) was stratified and 
compared with types of microbial organisms. In 
patients with age ranges from 25 – 45 years, frequency 
and percentages of Ecoli, Streptococcal Pneumonia, 
Staphauerous, and Klebsiella was 54 (57.4), 23 (67.6) 
and 08 (36.4) respectively, Similarly in patients with 
age ranges from 46 – 65 years, frequency and 
percentages of Ecoli, Streptococcal Pneumonia, 
Staphauerous, and Klebsiella was 11 (36.2), 11 (32.4) 
and 08 (36.4) respectively. The post-stratification 
comparison was done as shown in Table 2. 
Effect modifier like gender was stratified and 
compared with types of microbial organisms. In male 
patients, frequency and percentages of Ecoli, 
Streptococcal Pneumonia, Staphauerous, and 
Klebsiella were 46 (48.9), 16 (47.1) and 08 (36.4) 
respectively. Similarly in female patients, frequency 
and percentages of Ecoli, Streptococcal Pneumonia, 
Staphauerous, and Klebsiella were 48 (51.1), 18 (52.9) 
and 14 (63.3) respectively. Post-stratification was done 
by applying the chi-square test which was statistically 
significant (p-value 0.567), as shown in Table 3. 
 
 
 
Table 1: Frequency and percentages of the type of 
Microbial Organisms 
Organism Frequency Percent 
E Coli 94 62.7 
Streptococcal pnuemonia 34 22.7 
Staph aureus and 
Klebsiella 
22 14.7 
Total 150 100.0 
 
Table 2: Effect modifier like Age with Type of 
Microbial Organisms 
Type of 
Microbial  
Organism 
Age group (years) p-
value 
25 - 45 46 - 65 > 65  
E Coli 54 34 6  
 
 
0.003 
57.4% 36.2% 6.4% 
Streptococca
l pneumonia 
23 11 0 
67.6% 32.4% 0.0% 
Staphauerou
s and 
Klebsiella 
8 8 6 
36.4% 36.4% 27.3% 
Total 85 53 12  
56.7% 35.3% 8.0% 
 
Table 3: Effect modifier like Gender with Type of 
Microbial Organisms 
Type of 
Microbial 
Organism 
Gender p-value 
Males Females 
E Coli 46 48 
0.567 
48.9% 51.1% 
Streptococcal 
Pneumonia 
16 18 
47.1% 52.9% 
Staph. Aureus 
and Klebsiella 
08 14 
36.4% 63.3% 
Total 70 80 
46.7% 53.3% 
 
 
Discussion 
 
Liver cirrhosis constitutes a remarkable contributor to 
mortality worldwide.11 Portal hypertension is the main 
causative factor for most of the complications of 
cirrhosis.12 50% of patients of compensated cirrhosis 
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develop ascites within 10 years; which is mostly the 
earliest sign of portal hypertension.13 Cirrhotic patients 
with portal hypertension have poor prognosis without 
transplantation and development of spontaneous 
bacterial peritonitis (SBP) further accelerates the 
disease progression14 and mortality of the condition.15 
Despite an improvement in patient care, mortality 
after a single episode of SBP is estimated to be 32.5% at 
1 month and 66.2% after 1 year.16 Without prophylactic 
antibiotics; two-thirds of these patients have 
recurrences of infection within 12 months.17 Patients of 
cirrhosis with higher serum bilirubin, Child-Pugh 
stage C, and thrombocytopenia are more likely to 
develop SBP.18 Primary prevention for SBP is endorsed 
in patients with ascites if ascitic fluid protein 
concentration is low, or there is renal dysfunction, as 
characterized by serum creatinine of >1.2mg/dL, 
BUN>25mg/dL, or serum sodium ≤130mEq/L.19 
Norfloxacin is preferably the recommended primary 
prophylaxis agent for patients with a previous episode 
of SBP.20,21 It is defined as a bacterial infection of the 
ascitic fluid without a recognizable intra-abdominal 
source. The Worldwide incidence of spontaneous 
bacterial peritonitis in hospitalized patients with 
cirrhosis is 7–23%, while in Pakistan it is reported to be 
33%.22 Translocation of bacteria from the intestinal 
lumen to extra-intestinal sites or mesenteric nodes is 
the main pathophysiologic mechanism. This is due to 
increased permeability of gut in cirrhotic patients; 
which is brought about by defective local as well as 
systemic immunity in the backdrop of altered gut flora 
in patients with portal hypertension.23 
Gram-negative bacteria are the most common culprit 
when they leak into the blood after overwhelming the 
quarantine of mesenteric nodes.24 Subsequently, they 
settle in the ascitic fluid and lead to spontaneous 
bacterial peritonitis.25 Thus most causative organisms 
belong to intestinal flora26, most commonly E. Coli or a 
Klebsiella is involved.27  Recognition of pathogens is 
very important for the choice of antibiotic treatment.28 
But microbial cultures take time; considering the high 
mortality risk of SBP, antibiotics should be 
commenced before culture results. This is mostly 
guided by the prior knowledge of the microbial 
spectrum in these patient groups.29 
In our study, the mean age of patients was 32.3+9.31 
with ranges from 25 to 70 years similar to a study done 
by D’Amico G et al30 where the mean age of patients 
was 50.20±14.39 years.  In our study, male patients 
were 70 (46.7%), whereas 80 (53.3%) were females. In 
our study frequency and percentages of Ecoli and 
Streptococcal Pneumonia were 94 (62.7) and 34 (22.7) 
respectively, whereas frequency and percentages of 
staph. Aureus and Klebsiella were 22 (14.7). Similarly 
in a study by Shizuma et al.frequency and percentages 
of Ecoli and Streptococcal Pneumonia was 8(66.6) and 
2(16.6) respectively, whereas frequency and 
percentages of Klebsiella were 1(8.33).31 
Recognition of risk factors can determine the patients 
requiring the primary prophylaxis.32 In addition to the 
conventional risk factors mentioned above, increased 
ascetic fluid polymorph (PMN) count is also 
considered a risk factor for SBP32. Recently, C-Reactive 
protein (CRP) is also being investigated as a prognostic 
factor in cirrhotic patients with SBP.33 Literature 
suggests higher 1-month mortality in patients with 
SBP who have positive bacterial cultures.34 SBP is 
frequently followed by sepsis, renal dysfunction, and 
encephalopathy; all of which further pave the path for 
worse outcomes.35 This emphasizes the need for 
vigilance on the part of clinicians for early diagnosis 
and prompt treatment of this condition in order to 
improve the short and long term mortality. With the 
help of our study and new emerging data, we can 
identify risk factors for SBP development and pattern 
of microbial flora under current circumstances which 
will help in early aggressive treatment to decrease 
mortality. However, our study has some limitations, 
such as the limited sample size and some possible 
recruiting bias at a tertiary care hospital.  
 
Conclusion 
  
The study concludes that the frequency of 
spontaneous bacterial peritonitis is substantially high 
in cirrhotic patients. It may present with typical or 
atypical features so, a high index of suspicion should 
be maintained for its timely diagnosis and treatment. 
Knowledge of the microbial spectrum in this condition 
can help achieve this goal. 
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